Trial Profile
Study of intravitreal ranibizumab in age-related macular degeneration patients with hemorrhagic choroidal neovascularization.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 22 Sep 2015 New trial record